Navigation Links
Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance
Date:2/12/2008

Other assets (54,967) (7,033)

Accounts payable and

accrued expenses 382,898 (19,764)

Other liabilities 76,041 (31,641)

Net cash provided by

operating activities 384,856 319,917

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchases of property and equipment (96,867) (159,917)

Acquisition of intangible assets (107,246) (115,850)

Proceeds from sale of investment 12,291 -

Sales and (purchases) of

available-for-sale investments, net 18,876 255,391

Net cash used for

investing activities (172,946) (20,376)

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from exercises of common

stock options 93,900 143,491

Windfall tax benefits from stock-based

compensation 13,993 27,189

Acquisition of treasury stock (7,105) (4,418)

Payments on and retirements of long-term

debt (3,853) (188,886)

Net cash provided by (used for)

financing activities 96,935 (22,624)

EFFECT OF EXCHANGE RATE CHANGES ON

CASH AND CASH EQUIVALENTS 13,312 14,535

NET INCREASE IN CASH AND CASH EQUIVALENTS 322,157 291,452

CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 496,512 205,060

CASH AND CASH EQUIVALENTS, END OF YEAR $818,669 $496,512

CEPHALON, INC. AND SUBSIDIARIES


'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. CNS Response Announces Fiscal Third Quarter 2007 Results
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Martek to Announce Third Quarter 2007 Results on September 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email: